Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis

Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis

Background: TNF inhibitors (TNFis) are widely used for the treatment of rheumatoid arthritis (RA), although the response rates to this therapy in patients with RA remains heterogeneous and < 50% achieve remission (REM).Objective: To analyze baseline peripheral blood leukocytes profiles in ord...

Full description

Bibliographic Details
Main Authors: Eulalia Rodríguez-Martín, Israel Nieto-Gañán, Borja Hernández-Breijo, Cristina Sobrino, Carlota García-Hoz, Javier Bachiller, Ana Martínez-Feito, Victoria Navarro-Compán, Paloma Lapuente-Suanzes, Gema Bonilla, Dora Pascual-Salcedo, Garbiñe Roy, Teresa Jurado, Pilar Nozal, Mónica Vázquez-Díaz, Alejandro Balsa, Luisa M. Villar, Chamaida Plasencia-Rodríguez
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis
TNF inhibitors
biomarkers
lymphocyte subsets
remission
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.01913/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.01913/full

Similar Items